Lexicon Pharmaceuticals, Inc. (LXRX)
1.82
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.825
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals EPS Diluted (Quarterly) : -0.0726 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0726 |
| March 31, 2026 | -0.0026 |
| December 31, 2025 | -0.0427 |
| September 30, 2025 | -0.0351 |
| June 30, 2025 | 0.0089 |
| March 31, 2025 | -0.0699 |
| December 31, 2024 | -0.0934 |
| September 30, 2024 | -0.1793 |
| June 30, 2024 | -0.1719 |
| March 31, 2024 | -0.1972 |
| December 31, 2023 | -0.197 |
| September 30, 2023 | -0.2063 |
| June 30, 2023 | -0.2193 |
| March 31, 2023 | -0.169 |
| December 31, 2022 | -0.1616 |
| September 30, 2022 | -0.1337 |
| June 30, 2022 | -0.1643 |
| March 31, 2022 | -0.1574 |
| December 31, 2021 | -0.172 |
| September 30, 2021 | -0.1586 |
| June 30, 2021 | -0.1251 |
| March 31, 2021 | -0.1462 |
| December 31, 2020 | -0.0449 |
| September 30, 2020 | 0.7027 |
| June 30, 2020 | -0.6451 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.6252 |
| December 31, 2019 | -0.4812 |
| September 30, 2019 | 1.949 |
| June 30, 2019 | -0.2166 |
| March 31, 2019 | -0.2055 |
| December 31, 2018 | -0.1584 |
| September 30, 2018 | -0.2587 |
| June 30, 2018 | -0.3264 |
| March 31, 2018 | -0.3958 |
| December 31, 2017 | -0.27 |
| September 30, 2017 | -0.29 |
| June 30, 2017 | -0.33 |
| March 31, 2017 | -0.33 |
| December 31, 2016 | -0.31 |
| September 30, 2016 | -0.35 |
| June 30, 2016 | -0.37 |
| March 31, 2016 | -0.34 |
| December 31, 2015 | 0.76 |
| September 30, 2015 | -0.34 |
| June 30, 2015 | -0.27 |
| March 31, 2015 | -0.28 |
| December 31, 2014 | -0.0346 |
| September 30, 2014 | -0.56 |
| June 30, 2014 | -0.35 |
| March 31, 2014 | -0.42 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.620 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.78M |
| Revenue (Quarterly) | 0.692M |
| Total Expenses (Quarterly) | 32.47M |
| Enterprise Value | 678.42M |
| Gross Profit Margin (Quarterly) | 79.62% |
| Profit Margin (Quarterly) | -4.59K% |
| Earnings Yield | -8.41% |
| Normalized Earnings Yield | -8.028 |